Whole Genome And Exome Sequencing Market is Projected to Grow Expeditiously: to Reach $6.11 Billion by 2029

 For those planning market entry or expansion, this report lays out critical data and expert analysis on the whole genome and exome sequencing industry landscape.

 

 How Much Is The Whole Genome And Exome Sequencing Market Worth?
 The whole genome and exome sequencing market size has grown exponentially in recent years. It will grow from $2.02 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 24.5%. The growth in the historic period can be attributed to decreasing sequencing costs, rise in genetic disorders, clinical applications, genomic data repositories, advancements in bioinformatics.
 
 The whole genome and exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $6.11 billion in 2029 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to population genomics initiatives, rising demand for precision medicine, advancements in single-cell sequencing, expansion of non-invasive prenatal testing (NIPT), application in rare disease research. Major trends in the forecast period include expanded clinical adoption, rapid advancements in sequencing technologies, rise of population-scale genomic studies, integration of artificial intelligence (AI) and machine learning (ML), expanding applications in oncology.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
 
 What Are The Current Leading Growth Drivers For Whole Genome And Exome Sequencing Market?
 The rising demand for personalized medicine is expected to propel the growth of the whole genome and exome sequencing market in the future. Personalized medicine is an approach to medical treatment that tailors healthcare decisions and interventions to the individual characteristics of each patient, considering factors such as genetics, environment, and lifestyle. Whole genome and exome sequencing is used in personalized medicine by providing a comprehensive analysis of an individual’s genetic makeup, allowing for tailored healthcare decisions and interventions based on their unique genetic, environmental, and lifestyle factors. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes the understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines are expected to be on the market in 2022. Furthermore, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Further, out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized. Therefore, the rising demand for personalized medicine is driving the growth of the whole genome and exome sequencing market.
 
 Which Segment Accounted For The Largest Whole Genome And Exome Sequencing Market Share?
 The whole genome and exome sequencingmarket covered in this report is segmented — 
 
 1) By Product Type: Kits; Instruments
 2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
 3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
 4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
 
 Subsegments:
 1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits
 2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems
 
 Whole Genome And Exome Sequencing Market Emerging Trends And Opportunities
 Major companies operating in the whole genome and exome sequencing markets are increasing their focus on developing advanced technological solutions, such as ultra-fast NGS (next-generation sequencing) analysis, to gain a competitive edge in the market. Ultra-fast NGS analysis is a technological innovation that enables the processing of next-generation sequencing (NGS) data at an exceptionally high speed, significantly reducing the time required for genomic data analysis. For instance, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, launched the ultra-fast NGS analysis platform. This platform offers features such as processing a whole genome in 25 minutes for $1 in cloud computing costs, promoting efficiency, affordability, and scalability; its technological innovation significantly enhances genomic data analysis speed and accessibility, thus holding considerable importance in the whole genome and exome sequencing market by enabling rapid decision-making and wider adoption of personalized medicine.
 
 Which Are The Top Companies To Hold The Market Share In Whole Genome And Exome Sequencing Market?
 Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan
 
 View the full whole genome and exome sequencing market report here:
 https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report
 
 Which Region Is Projected To Account For The Largest Share Of The Whole Genome And Exome Sequencing Market?
 North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company